Increased expression of placental growth factor in high-grade endometrial carcinoma.

Abstract

Placental growth factor (PlGF), a homolog of vascular endothelial growth factor (VEGF), exerts pleiotropic functions in cancer by affecting tumor cells as well as endothelial and inflammatory cells. Moreover, PlGF expression correlates with tumor stage, recurrence, metastasis and patient outcome in different types of cancer. Recently, administration of anti-PlGF therapy reduced tumor growth and metastasis in preclinical tumor models. In the present study, we evaluated the diagnostic and prognostic value of systemic and local expression of PlGF in primary endometrial carcinomas. PlGF levels in tumor lysates (n=128) and serum (n=88) of patients with primary endometrial cancer were determined using ELISA. PlGF mRNA expression in endometrial carcinoma tissues was quantified by quantitative qRT-PCR. Results were compared to endometrial cancer stage and grade. Systemic PlGF levels were not altered in patients with endometrial cancer (FIGO stage I-II-III) as compared to healthy controls. Only in FIGO stage IV patients, serum PlGF levels were slightly increased. Local PlGF mRNA and protein expression in endometrial tumors progressively increased with tumor grade. In endometrioid carcinomas, PlGF mRNA expression was significantly increased in endometrioid grade 3 tumors as compared to normal endometrial tissue. PlGF protein expression was significantly increased in endometrioid grade 2 and 3 carcinomas and in serous carcinomas as compared to normal endometrial tissue. Our study showed that systemic/serum PlGF levels cannot be used as a diagnostic or prognostic marker in endometrial cancer. However, the increased local expression of PlGF, primarily in high-grade carcinomas, underscores the possibility for preclinical assessment of anti-PlGF therapy in endometrial cancer.

• Authors: Lieve Coenegrachts, Stefanie Schrauwen, Rita Van Bree, Evelyn Despierre, Catherine Luyten, Bart Jonckx, Jean Marie Stassen, Ignace Vergote, Frédéric Amant
• Journal: Oncology reports (Oncol Rep) Vol. 29 Issue 2 Pg. 413-8 (Feb 2013) ISSN: 1791-2431 [Electronic] Greece
• PMID: 23232836 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers, Tumor
• PGF protein, human
• Pregnancy Proteins
• RNA, Messenger
• Placenta Growth Factor

Topics

• Adult
• Aged
• Aged, 80 and over
• Analysis of Variance
• Biomarkers, Tumor (blood, metabolism)
• Carcinoma (blood, metabolism, pathology)
• Case-Control Studies
• Endometrial Neoplasms (blood, metabolism, pathology)
• Female
• Humans
• Middle Aged
• Multivariate Analysis
• Neoplasm Grading
• Neoplasm Staging
• Placenta Growth Factor
• Pregnancy Proteins (blood, metabolism)
• RNA, Messenger (metabolism)
• Statistics, Nonparametric